{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T05:02:48Z","timestamp":1784350968610,"version":"3.55.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,17]],"date-time":"2013-07-17T00:00:00Z","timestamp":1374019200000},"content-version":"vor","delay-in-days":2785,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1016\/j.virol.2005.08.008","type":"journal-article","created":{"date-parts":[[2005,9,15]],"date-time":"2005-09-15T10:15:38Z","timestamp":1126779338000},"page":"128-140","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Identification and preliminary characterization of vaccinia virus (Dryvax) antigens recognized by vaccinia immune globulin"],"prefix":"10.1016","volume":"343","author":[{"given":"Agnes","family":"Jones-Trower","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alonzo","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clement A.","family":"Meseda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arunima","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry P.","family":"Weir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Merchlinsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2005.08.008_bib1","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.virol.2004.05.004","article-title":"Antibodies against the extracellular enveloped virus B5R protein are mainly responsible for the EEV neutralizing capacity of vaccinia immune globulin","volume":"325","author":"Bell","year":"2004","journal-title":"Virology"},{"issue":"3","key":"10.1016\/j.virol.2005.08.008_bib2","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1086\/380906","article-title":"Dose-dependent neutralizing-antibody responses to vaccinia","volume":"189","author":"Belshe","year":"2004","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2005.08.008_bib3","doi-asserted-by":"crossref","first-page":"9458","DOI":"10.1073\/pnas.1233578100","article-title":"Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses","volume":"100","author":"Belyakov","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"2","key":"10.1016\/j.virol.2005.08.008_bib4","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1006\/abio.1999.4364","article-title":"A Luminescent ruthenium complex for ultrasensitive detection of proteins immobilized on membrane supports","volume":"276","author":"Berggren","year":"1999","journal-title":"Anal. Biochem."},{"issue":"5","key":"10.1016\/j.virol.2005.08.008_bib5","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1099\/0022-1317-79-5-1159","article-title":"Modified vaccinia virus Ankara undergoes limited replication in human cells and lacks several immunomodulatory proteins: implications for use as a human vaccine","volume":"79","author":"Blanchard","year":"1998","journal-title":"J. Gen. Virol."},{"issue":"2","key":"10.1016\/j.virol.2005.08.008_bib6","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0166-3542(03)00008-1","article-title":"Pathogenesis and potential antiviral therapy of complications of smallpox vaccination","volume":"58","author":"Bray","year":"2003","journal-title":"Anti. Res."},{"key":"10.1016\/j.virol.2005.08.008_bib7","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1099\/vir.0.18942-0","article-title":"Vaccinia virus transcription","volume":"84","author":"Broyles","year":"2003","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2005.08.008_bib8","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1006\/viro.1997.8845","article-title":"Host range and cytopathogenicity of the highly attenuated MVA strain of vaccinia virus: propagation and generation of recombinant viruses in a nonhuman mammalian cell line","volume":"238","author":"Carroll","year":"1997","journal-title":"Virology"},{"issue":"3","key":"10.1016\/j.virol.2005.08.008_bib9","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1073\/pnas.0408782102","article-title":"Profiling the humoral immune response to infection by using proteome microarrays: high-throughput vaccine and diagnostic antigen discovery","volume":"102","author":"Davies","year":"2005","journal-title":"Proc. Nat. Acad. Sci. U.S.A."},{"issue":"1","key":"10.1016\/j.virol.2005.08.008_bib10","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1128\/jvi.66.1.386-398.1992","article-title":"Identification and characterization of vaccinia genes encoding proteins that are highly antigenic in animals and are immunodominant in vaccinated humans","volume":"66","author":"Demkowicz","year":"1992","journal-title":"J. Virol."},{"issue":"39","key":"10.1016\/j.virol.2005.08.008_bib11","doi-asserted-by":"crossref","first-page":"12677","DOI":"10.1021\/bi9615699","article-title":"Cysteine scanning mutagenesis at 40 of 76 positions in villin headpiece maps the F-actin binding site and structural features of the domain","volume":"35","author":"Doering","year":"1996","journal-title":"Biochemistry"},{"issue":"2","key":"10.1016\/j.virol.2005.08.008_bib12","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1099\/0022-1317-79-2-347","article-title":"Highly attenuated modified vaccinia virus Ankara replicates in baby hamster kidney cells, a potential host for virus propagation, but not in various human transformed and primary cells","volume":"79","author":"Drexler","year":"1998","journal-title":"J. Gen. Virol."},{"issue":"1","key":"10.1016\/j.virol.2005.08.008_bib13","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1073\/pnas.262668999","article-title":"Identification of vaccinia virus epitope-specific HLA-A*0201-restricted T cells and comparative analysis of smallpox vaccines","volume":"100","author":"Drexler","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.virol.2005.08.008_bib14","series-title":"Current Protocols in Molecular Biology","first-page":"16.17.1","article-title":"Generation of recombinant vaccinia viruses","author":"Earl","year":"1991"},{"key":"10.1016\/j.virol.2005.08.008_bib15","first-page":"16.16.1","article-title":"Preparation of cell cultures and vaccinia virus stocks","volume":"vol. 3","author":"Earl","year":"1998"},{"key":"10.1016\/j.virol.2005.08.008_bib16","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nature02331","article-title":"Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox","volume":"428","author":"Earl","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.virol.2005.08.008_bib17","first-page":"16.19.1","article-title":"Gene expression using the vaccinia virus\/T7 RNA polymerase hybrid system","volume":"vol. 3","author":"Elroy-Stein","year":"1998"},{"key":"10.1016\/j.virol.2005.08.008_bib18","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1086\/340517","article-title":"Primary induction of human CD8+ cytotoxic T lymphocytes and interferon-\u03b3-producing T cells after smallpox vaccination","volume":"185","author":"Ennis","year":"2002","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2005.08.008_bib19","series-title":"Smallpox and its Eradication","author":"Fenner","year":"1988"},{"key":"10.1016\/j.virol.2005.08.008_bib20","doi-asserted-by":"crossref","first-page":"10230","DOI":"10.1128\/JVI.78.19.10230-10237.2004","article-title":"Protective immunity to vaccinia virus induced by vaccination with multiple recombinant outer membrane proteins of intracellular and extracellular virions","volume":"78","author":"Fogg","year":"2004","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.virol.2005.08.008_bib21","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1086\/375825","article-title":"Smallpox vaccination: a review: Part II. Adverse events","volume":"37","author":"Fulginiti","year":"2003","journal-title":"Clin. Infect. Dis."},{"issue":"1","key":"10.1016\/j.virol.2005.08.008_bib22","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1006\/viro.1998.9516","article-title":"Neutralizing and protective antibodies directed against vaccinia virus envelope antigens","volume":"254","author":"Galmiche","year":"1999","journal-title":"Virology"},{"issue":"14","key":"10.1016\/j.virol.2005.08.008_bib23","doi-asserted-by":"crossref","first-page":"6460","DOI":"10.1128\/JVI.75.14.6460-6471.2001","article-title":"Repression of vaccinia virus Holliday junction resolvase inhibits processing of viral DNA into unit-length genomes","volume":"75","author":"Garcia","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2005.08.008_bib24","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1542\/peds.55.3.342","article-title":"Smallpox vaccination reactions, prophylaxis and therapy of complications","volume":"55","author":"Goldstein","year":"1975","journal-title":"Pediatrics"},{"issue":"5406","key":"10.1016\/j.virol.2005.08.008_bib25","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1126\/science.283.5406.1279","article-title":"The looming threat of bioterrorism","volume":"283","author":"Henderson","year":"1999","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.virol.2005.08.008_bib26","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1006\/viro.1999.0096","article-title":"DNA vaccination with vaccinia virus L1R and A33R genes protects mice against a lethal poxvirus challenge","volume":"266","author":"Hooper","year":"2000","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.virol.2005.08.008_bib27","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0042-6822(02)00038-7","article-title":"Four-gene-combination DNA vaccine protects mice against a lethal vaccinia virus challenge and elicits appropriate antibody responses in nonhuman primates","volume":"306","author":"Hooper","year":"2003","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.virol.2005.08.008_bib28","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1006\/viro.1994.1405","article-title":"Identification of a vaccinia virus penetration protein","volume":"202","author":"Ichihashi","year":"1994","journal-title":"Virology"},{"key":"10.1016\/j.virol.2005.08.008_bib29","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1542\/peds.18.2.177","article-title":"Hyperimmune vaccinal gamma globulin: source, evaluation and use in prophylaxis and therapy","volume":"18","author":"Kempe","year":"1956","journal-title":"Pediatrics"},{"key":"10.1016\/j.virol.2005.08.008_bib30","first-page":"41","article-title":"The use of vaccinia hyperimmune gamma-globulin in the prophylaxis of smallpox","volume":"25","author":"Kempe","year":"1961","journal-title":"Bull. World Health Organ."},{"issue":"7","key":"10.1016\/j.virol.2005.08.008_bib31","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1128\/JVI.74.7.3353-3365.2000","article-title":"Vaccinia virus envelope H3L protein binds to cell surface heparan sulfate and is important for intracellular mature virion morphogenesis and virus infection in vitro and in vivo","volume":"74","author":"Lin","year":"2000","journal-title":"J. Virol."},{"issue":"12","key":"10.1016\/j.virol.2005.08.008_bib32","doi-asserted-by":"crossref","first-page":"3910","DOI":"10.1128\/jvi.61.12.3910-3919.1987","article-title":"Structural and functional studies of a 39,000-Mr Immunodominant protein of vaccinia virus","volume":"61","author":"Maa","year":"1987","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2005.08.008_bib33","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/BF01641272","article-title":"Abstammung, eigenshaften und verwendung des attenuierten vaccinia-stammes MVA [Passage history, properties, and applicability of the attenuated vaccinia virus strain MVA]","volume":"3","author":"Mayr","year":"1975","journal-title":"Infection"},{"issue":"11","key":"10.1016\/j.virol.2005.08.008_bib34","doi-asserted-by":"crossref","first-page":"3550","DOI":"10.1128\/jvi.61.11.3550-3554.1987","article-title":"Mapping and nucleotide sequence of the vaccinia virus gene that encodes a 14-kilodalton fusion protein","volume":"61","author":"Rodriguez","year":"1987","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2005.08.008_bib35","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/S0140-6736(73)92215-0","article-title":"Experience of anti-vaccinia immunoglobulin in the United Kingdom","author":"Sharp","year":"1973","journal-title":"Lancet"},{"key":"10.1016\/j.virol.2005.08.008_bib36","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1099\/0022-1317-83-12-2915","article-title":"The formation and function of extracellular enveloped vaccinia virus","volume":"83","author":"Smith","year":"2002","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2005.08.008_bib37","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/S0022-3476(65)80221-9","article-title":"Complications of smallpox vaccination. Effects of vaccinia immune globulin therapy","volume":"67","author":"Sussman","year":"1965","journal-title":"J. Pediatr."},{"key":"10.1016\/j.virol.2005.08.008_bib38","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/0042-6822(86)90405-8","article-title":"Identification of antigenic determinants by polyclonal and hybridoma antibodies induced during the course of infection by vaccinia virus","volume":"148","author":"Wilton","year":"1986","journal-title":"Virology"},{"key":"10.1016\/j.virol.2005.08.008_bib39","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1006\/viro.1995.1378","article-title":"A myristylated membrane protein encoded by the vaccinia virus L1R open reading frame is the target of potent neutralizing monoclonal antibodies","volume":"211","author":"Wolffe","year":"1995","journal-title":"Virology"},{"issue":"13","key":"10.1016\/j.virol.2005.08.008_bib40","doi-asserted-by":"crossref","first-page":"4590","DOI":"10.1073\/pnas.0401165101","article-title":"Highly attenuated smallpox vaccine protects mice with and without immune deficiencies against pathogenic vaccinia virus challenge","volume":"101","author":"Wyatt","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"2","key":"10.1016\/j.virol.2005.08.008_bib41","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0378-1119(94)90067-1","article-title":"Identification of the gene encoding vaccinia virus immunodominant protein p35","volume":"147","author":"Zinoviev","year":"1994","journal-title":"Gene"}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682205005027?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682205005027?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T23:37:54Z","timestamp":1758584274000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682205005027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["S0042682205005027"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2005.08.008","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2005,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification and preliminary characterization of vaccinia virus (Dryvax) antigens recognized by vaccinia immune globulin","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2005.08.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}